149980 Stock Chart & Stats
₩5100.00
-₩400.00(-7.27%)
―
--
Day’s Range― - ―
52-Week Range₩3,770.00 - ₩9,510.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)40.45K
Market Cap
₩94.59B
Enterprise Value₩60.56K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)31.3
Beta0.13
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,199,045
10 Day Avg. Volume30,807
30 Day Avg. Volume40,446
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
149980 FAQ
What was Hironic Co.Ltd’s price range in the past 12 months?
Hironic Co.Ltd lowest stock price was ₩3770.00 and its highest was ₩9510.00 in the past 12 months.
What is Hironic Co.Ltd’s market cap?
Hironic Co.Ltd’s market cap is ₩94.59B.
When is Hironic Co.Ltd’s upcoming earnings report date?
Hironic Co.Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 85 days.
How were Hironic Co.Ltd’s earnings last quarter?
Currently, no data Available
Is Hironic Co.Ltd overvalued?
According to Wall Street analysts Hironic Co.Ltd’s price is currently Undervalued.
Does Hironic Co.Ltd pay dividends?
Hironic Co.Ltd does not currently pay dividends.
What is Hironic Co.Ltd’s EPS estimate?
Hironic Co.Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hironic Co.Ltd have?
Hironic Co.Ltd has 17,199,045 shares outstanding.
What happened to Hironic Co.Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hironic Co.Ltd?
Currently, no hedge funds are holding shares in KR:149980
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sam-A Pharm. Co., Ltd.
―
Osang Healthcare Co. Ltd.
―
iNtRON Biotechnology, Inc.
―
DRB Industrial Co., Ltd.
―
Enzychem Lifesciences Corp.
―